Faisal S Dar1, Abu Bakar H Bhatti2, Ammal I Qureshi1, Nusrat Y Khan1, Zahaan Eswani1, Haseeb H Zia1, Eitzaz U Khan3, Nasir A Khan3, Atif Rana4, Najmul H Shah5, Mohammad Salih5, Rashid Nazer4. 1. Department of HPB Surgery and Liver Transplantation, Shifa International Hospital, Sector H-8/4, Pitras Bukhari Road, Islamabad, Pakistan. 2. Department of HPB Surgery and Liver Transplantation, Shifa International Hospital, Sector H-8/4, Pitras Bukhari Road, Islamabad, Pakistan. abubakar.hafeez@yahoo.com. 3. Department of Anesthesiology, Shifa International Hospital, Islamabad, Pakistan. 4. Department of Radiology, Shifa International Hospital, Islamabad, Pakistan. 5. Department of Gastroenterology and Hepatology, Shifa International Hospital, Islamabad, Pakistan.
Abstract
BACKGROUND: There is paucity of data on intermediate-term post liver transplant outcomes from South Asia. The objective of this study was to determine survival outcomes in patients who underwent living donor liver transplantation (LDLT) in a busy liver transplant center in Pakistan. METHODS: This study was a review of patients who underwent LDLT between 2012 and 2016. A total of 321 patients were included in this study. Early (within 90 days) and late (>90 days) morbidity and mortality was assessed. Estimated 1- and 4-year survival was determined. RESULTS: Median age was 48 (18-73) years. Male to female ratio was 4.5:1. Out of total 346 complications, 184 (57.3%) patients developed 276 (79.7%) complications in early post-transplant period, whereas there were 70 (21.3%) late complications. Most common early complication was pleural effusion in 46 (16.6%) patients. Biliary complications were the most common late complication and were seen in 31/70 (44.2%) patients. Overall 21.4% patients had a biliary complication. The 3-month mortality was 14%. The estimated 1- and 4-year OS for a MELD cutoff of 30 was 84.5 versus 72 and 80 versus 57% (P = 0.01). There was no donor mortality. CONCLUSION: Acceptable intermediate-term post-transplant outcomes were achieved with LDLT. There is a need to improve outcomes in high-MELD patients.
BACKGROUND: There is paucity of data on intermediate-term post liver transplant outcomes from South Asia. The objective of this study was to determine survival outcomes in patients who underwent living donor liver transplantation (LDLT) in a busy liver transplant center in Pakistan. METHODS: This study was a review of patients who underwent LDLT between 2012 and 2016. A total of 321 patients were included in this study. Early (within 90 days) and late (>90 days) morbidity and mortality was assessed. Estimated 1- and 4-year survival was determined. RESULTS: Median age was 48 (18-73) years. Male to female ratio was 4.5:1. Out of total 346 complications, 184 (57.3%) patients developed 276 (79.7%) complications in early post-transplant period, whereas there were 70 (21.3%) late complications. Most common early complication was pleural effusion in 46 (16.6%) patients. Biliary complications were the most common late complication and were seen in 31/70 (44.2%) patients. Overall 21.4% patients had a biliary complication. The 3-month mortality was 14%. The estimated 1- and 4-year OS for a MELD cutoff of 30 was 84.5 versus 72 and 80 versus 57% (P = 0.01). There was no donor mortality. CONCLUSION: Acceptable intermediate-term post-transplant outcomes were achieved with LDLT. There is a need to improve outcomes in high-MELD patients.
Authors: Kim M Olthoff; Michael M Abecassis; Jean C Emond; Igal Kam; Robert M Merion; Brenda W Gillespie; Lan Tong Journal: Liver Transpl Date: 2011-07 Impact factor: 5.799
Authors: Ajacio Brandão; Sandra C Fuchs; Ana L Gleisner; C Marroni; Maria L Zanotelli; Guido Cantisani Journal: Clin Transplant Date: 2009-02-05 Impact factor: 2.863
Authors: Charles Miller; Sander Florman; Leona Kim-Schluger; Patrick Lento; Julia De La Garza; Josephine Wu; Boxun Xie; Wandi Zhang; Edward Bottone; David Zhang; Myron Schwartz Journal: Liver Transpl Date: 2004-10 Impact factor: 5.799
Authors: Mathew Jacob; Lynn P Copley; James D Lewsey; Alex Gimson; Giles J Toogood; Mohamed Rela; Jan H P van der Meulen Journal: Liver Transpl Date: 2004-07 Impact factor: 5.799
Authors: Henrik Petrowsky; Abbas Rana; Fady M Kaldas; Anuj Sharma; Johnny C Hong; Vatche G Agopian; Francisco Durazo; Henry Honda; Jeffrey Gornbein; Victor Wu; Douglas G Farmer; Jonathan R Hiatt; Ronald W Busuttil Journal: Ann Surg Date: 2014-06 Impact factor: 12.969
Authors: Abu Bakar H Bhatti; Faisal S Dar; Ammal I Qureshi; Nusrat Y Khan; Haseeb H Zia; Siraj Haider; Najmul H Shah; Atif Rana Journal: J Clin Exp Hepatol Date: 2019-05-01